1. Home
  2. INM vs FITBO Comparison

INM vs FITBO Comparison

Compare INM & FITBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INM
  • FITBO
  • Stock Information
  • Founded
  • INM 1981
  • FITBO N/A
  • Country
  • INM Canada
  • FITBO United States
  • Employees
  • INM N/A
  • FITBO 18616
  • Industry
  • INM Biotechnology: Pharmaceutical Preparations
  • FITBO Major Banks
  • Sector
  • INM Health Care
  • FITBO Finance
  • Exchange
  • INM Nasdaq
  • FITBO Nasdaq
  • Market Cap
  • INM 5.0M
  • FITBO N/A
  • IPO Year
  • INM N/A
  • FITBO N/A
  • Fundamental
  • Price
  • INM $2.00
  • FITBO $20.57
  • Analyst Decision
  • INM
  • FITBO
  • Analyst Count
  • INM 0
  • FITBO 0
  • Target Price
  • INM N/A
  • FITBO N/A
  • AVG Volume (30 Days)
  • INM 102.6K
  • FITBO N/A
  • Earning Date
  • INM 11-13-2025
  • FITBO N/A
  • Dividend Yield
  • INM N/A
  • FITBO N/A
  • EPS Growth
  • INM N/A
  • FITBO N/A
  • EPS
  • INM N/A
  • FITBO N/A
  • Revenue
  • INM $4,942,633.00
  • FITBO N/A
  • Revenue This Year
  • INM N/A
  • FITBO N/A
  • Revenue Next Year
  • INM N/A
  • FITBO N/A
  • P/E Ratio
  • INM N/A
  • FITBO N/A
  • Revenue Growth
  • INM 7.50
  • FITBO N/A
  • 52 Week Low
  • INM $1.72
  • FITBO N/A
  • 52 Week High
  • INM $8.27
  • FITBO N/A
  • Technical
  • Relative Strength Index (RSI)
  • INM 38.56
  • FITBO 46.41
  • Support Level
  • INM $2.04
  • FITBO $20.44
  • Resistance Level
  • INM $2.14
  • FITBO $20.74
  • Average True Range (ATR)
  • INM 0.12
  • FITBO 0.24
  • MACD
  • INM -0.02
  • FITBO -0.02
  • Stochastic Oscillator
  • INM 0.00
  • FITBO 37.68

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.

About FITBO Fifth Third Bancorp Depositary Shares each representing a 1/1000th ownership interest in a share of Non-Cumulative Perpetual Preferred Stock Series K

Fifth Third Bancorp is a diversified financial-services company headquartered in Cincinnati. The company has over $210 billion in assets and operates numerous full-service banking branches and ATMs throughout Ohio, Kentucky, Indiana, Michigan, Illinois, Florida, Tennessee, West Virginia, Georgia, and North Carolina.

Share on Social Networks: